JD Supra: Mergers

SEPTEMBER 5, 2024

AB 3129 would establish a mandatory approval process for a broad range of healthcare-related transactions involving private equity funds and hedge funds, giving the California Attorney General (“CA AG”) broad authority to block or impose restrictions on transactions to protect public interest. By: Goodwin

Private Equity 172

Private Equity Healthcare Funds Equities 172

JD Supra: Mergers

JUNE 3, 2024

Private equity firms can breathe a sigh of relief after a federal judge dismissed claims that threatened to establish a precedent for holding private equity firms liable for certain actions by their portfolio companies. By: Troutman Pepper

Private Equity 172

Private Equity Equities Portfolio 172

JD Supra: Mergers

AUGUST 29, 2024

Audax Private Equity has announced it will acquire the clinical services business of Avantor (NYSE: AVTR). By: McGuireWoods LLP

Private Equity 149

Private Equity Equities Healthcare Business 149

JD Supra: Mergers

AUGUST 5, 2024

The Massachusetts legislative session for 2024 has come to a close without the passage of a bill that would have targeted private equity in healthcare.

Private Equity 167

Private Equity Healthcare Equities Funds 167

JD Supra: Mergers

AUGUST 1, 2024

At the end of last year, Holland & Knight predicted that "the current enforcement environment will continue into 2024 and will focus heavily on the healthcare industry, along with private equity transactions or 'roll-ups.' 15, 2023.)

Private Equity 167

Private Equity Healthcare Equities 167

JD Supra: Mergers

AUGUST 1, 2024

Private equity investment in health care has grown significantly over the past two decades, and the US government is starting to pay attention. The False Claims Act (FCA) appears to be the first avenue of enforcement, but private equity firms should be prepared for state. By: K&L Gates LLP

Private Equity 172

Private Equity Equities Medical Government 172

JD Supra: Mergers

AUGUST 15, 2024

private equity investors has reached an all-time high, and with capital on the sideline ready to deploy, pressure to get deals done is on the rise. Although the U.S. healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. Dry powder held by U.S.

Private Equity 172

Private Equity Healthcare Equities M&A 172

JD Supra: Mergers

MARCH 12, 2024

The year 2023 will be remembered as a challenging one for private equity (PE), with complexities to navigate on many fronts. Although overall transaction volume was significantly down, private equity funds still found. By: Akin Gump Strauss Hauer & Feld LLP

Private Equity 192

Private Equity Equities Debt Valuation 192

JD Supra: Mergers

FEBRUARY 28, 2024

Traditionally, private equity firms were seen as benign investors from an antitrust perspective. This is changing. In the past 12 months, PE-funded acquisitions have faced progressively more rigorous scrutiny by antitrust authorities. By: Allen & Overy LLP

Private Equity 187

Private Equity Equities Funds Investors 187

JD Supra: Mergers

JULY 25, 2024

2871, An Act Enhancing the Health Care Market Review Process (the Bill), to increase oversight of healthcare transactions involving private equity firms, real estate investment trusts, and management services organizations (MSOs). On July 18, 2024, the Massachusetts Senate passed S. By: Sheppard Mullin Richter & Hampton LLP

Private Equity 167

Private Equity Healthcare Equities Management 167

JD Supra: Mergers

AUGUST 13, 2024

A recent wave of state legislation is changing the course of healthcare transactions, and organizations (particularly private equity-backed organizations) that engage in mergers and acquisitions in the healthcare industry should prepare for increased scrutiny. By: BakerHostetler

Private Equity 167

Private Equity Healthcare Equities Mergers and Acquisitions 167

JD Supra: Mergers

JUNE 4, 2024

Private equity sponsors can exhale: A federal court recently stopped the Federal Trade Commission's (FTC) antitrust action that targeted private equity sponsor Welsh, Carson, Anderson & Stowe for the healthcare "roll-up" strategy of its anesthesia practice management portfolio company. Anesthesia Partners, Inc.

Private Equity 182

Private Equity Healthcare Equities Portfolio 182

JD Supra: Mergers

MAY 22, 2024

McGuireWoods recently held its 20th Annual Healthcare Private Equity and Finance Conference (HCPE Conference) in Chicago. The conference drew more than 1,000 professionals from private equity funds, senior and mezzanine lenders, and investment banks, as well as C-level executives, consultants and principals in the healthcare industry.

Private Equity 161

Private Equity Healthcare Finance Finance 161

JD Supra: Mergers

JUNE 12, 2024

Episode 7: Exploring the Role of Operating Partners in Private Equity In this episode of BRight Minds in Healthcare Delivery, Donna Cooper joins host Eric Tower for a conversation about her career and how her prior experience has influenced her current role as an operating partner. Donna explains the role of an operating partner at….

Private Equity 161

Private Equity Equities Healthcare 161

JD Supra: Mergers

JANUARY 9, 2024

As we begin 2024, we have highlighted the issues and trends that private equity (PE) investors should consider when evaluating transactions in the healthcare sector. W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity.

Private Equity 196

Private Equity Healthcare Equities Funds 196

JD Supra: Mergers

JULY 8, 2024

During the past 12 years, private equity (PE) firms have served as major investors in the U.S. health care market, participating in acquisitions and consolidations of physician practices across various specialties.

Private Equity 155

Private Equity Economics Equities Investors 155

Align Business Advisory Services

SEPTEMBER 5, 2024

In a groundbreaking shift for the NFL, the league is opening its doors to private equity investments, a move that has the potential to revolutionize team ownership structures and address longstanding challenges in the sports market.

Private Equity 67

Private Equity Equities Investment Investors 67

JD Supra: Mergers

MAY 21, 2024

What do private equity and growth capital investors look for when adding new companies to their portfolio, and what strategies do they apply to help those companies optimize capital? They covered the current private equity landscape, strategies for creating value, industry trends, various investment structures, and more.

Private Equity 167

Private Equity Equities Capital Mergers and Acquisitions 167

JD Supra: Mergers

MARCH 8, 2024

Private equity is squarely in the cross hairs of regulators; the Department of Justice Antitrust Division, the Federal Trade Commission, and the U.S. Department of Health and Human Services recently announced the launch of a joint inquiry into private equity ownership in the health care field. By: Ballard Spahr LLP

Private Equity 187

Private Equity Equities Acquisitions Trading 187

JD Supra: Mergers

MARCH 12, 2024

Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. By: Mayer Brown

Private Equity 177

Private Equity Healthcare Equities Acquisitions 177

JD Supra: Mergers

MARCH 12, 2024

On March 5, the FTC convened a workshop with regulators, academics and stakeholders to discuss the impact of private equity in the healthcare market. The workshop reflects the FTC and DOJ Antitrust Division’s recent focus on private equity and serial roll-up transactions more broadly as targets for antitrust enforcement.

Private Equity 167

Private Equity Healthcare Equities Acquisitions 167

JD Supra: Mergers

MAY 17, 2024

a federal district court granted private equity firm Welsh, Carson, Anderson & Stowe's motion to dismiss it from the Federal Trade Commission's (FTC) lawsuit alleging an anticompetitive scheme to drive up the price of anesthesia services by orchestrating a decade-long "roll-up" strategy to consolidate anesthesiology practices in Texas.

Private Equity 172

Private Equity Equities Trading IT 172

JD Supra: Mergers

APRIL 1, 2024

The California legislature is considering a bill that could severely impact the ability for private equity companies and hedge funds to operate in the California health care industry. By: Polsinelli

Private Equity 177

Private Equity Equities Funds Investment 177

JD Supra: Mergers

MARCH 8, 2024

A recent government initiative announced on March 5, 2024 signals that more antitrust scrutiny for private equity firms and asset managers is on the horizon. By: Paul Hastings LLP

Private Equity 161

Private Equity Equities Healthcare Asset Management 161

JD Supra: Mergers

MAY 28, 2024

The UK Takeover Panel (the Panel) has published a new framework for private sale processes. If you are a private equity investor considering potential P2P acquisitions after receiving initial soundings from management teams, then this new regime should be helpful in enabling early stage talks to happen in private.

Private Equity 167

Private Equity Sale Investors Equities 167

Deal Lawyers

JUNE 17, 2024

Woodruff Sawyer recently issued its “Guide to Insuring Fund Liability Risks for Venture Capital and Private Equity Firms.” ” The publication provides an overview of the key coverages and claims scenarios.

Private Equity 113

Private Equity Insurance Equities Funds 113

JD Supra: Mergers

MAY 30, 2024

The Federal Trade Commission’s (FTC) push against private equity roll-ups has hit a snag. Judge Hoyt found that the FTC had not adequately alleged that Welsh Carson “is violating” or “is about to violate” antitrust laws, as required under.

Private Equity 182

Private Equity Equities Trading 182

JD Supra: Mergers

MARCH 8, 2024

On March 5, the Federal Trade Commission (FTC) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care.” The event is part of the agency’s effort to publicize and encourage enforcement targeting private equity investments in health care.

Private Equity 182

Private Equity Equities Trading Capital 182

Deal Lawyers

JULY 12, 2024

The fourth quarter of 2023 saw an uptick in global M&A activity that’s continued through the second quarter of 2024, but until recently, Private Equity didn’t appear to participate in the rebound. According to a new PitchBook report on PE deal activity, that started to change in the second quarter.

Private Equity 100

Private Equity Equities M&A 100

JD Supra: Mergers

SEPTEMBER 25, 2023

USAP”), and the private equity firm Welsh, Carson, Anderson & Stowe (“Welsh Carson”), which created USAP, executed a multi-year anticompetitive scheme to consolidate anesthesiology practices in Texas, drive up the price of anesthesia services provided to Texas patients and boost their own profits. Anesthesia Partners, Inc.

Private Equity 283

Private Equity Equities Profitability Trading 283

JD Supra: Mergers

APRIL 22, 2024

A recently introduced California Assembly Bill (AB 3129), targeting private equity (PE) physician practice investments, is currently making its way through the legislative process.

Private Equity 172

Private Equity Equities Investment Acquisitions 172

JD Supra: Mergers

JUNE 12, 2024

Department of Health and Human Services’ (together the “Agencies”) request for information regarding consolidation in healthcare by private equity. Department of Justice, and the U.S. By: Sheppard Mullin Richter & Hampton LLP

Private Equity 167

Private Equity Healthcare Equities Trading 167

JD Supra: Mergers

MARCH 13, 2024

Private equity investment in the health care sector continues to be a significant area of focus for the U.S. On March 5, 2024, the Federal Trade Commission (FTC) hosted a public workshop to “examine the role of private equity investment in health care markets” (the FTC workshop). antitrust agencies.

Private Equity 155

Private Equity Equities Investment Trading 155

OfficeHours

AUGUST 9, 2023

To know if the buyside is right for you, let’s start with a textbook understanding of “What is private equity?” Private equity involves investing capital directly into private businesses that are not publicly traded on stock exchanges (that would be a hedge fund). Strategic thinking skills are essential.

Private Equity 130

Private Equity Equities Investment Banking Finance 130

Deal Lawyers

AUGUST 15, 2024

According to a recent PitchBook article, strategic buyers are increasingly willing to pay through the nose for assets held by private equity funds – and a lot of those funds are increasingly looking to strategic buyers to supply an off-ramp for their investments.

Private Equity 100

Private Equity Equities M&A Funds 100

Deal Lawyers

JULY 25, 2024

According to a recent Institutional Investor article, private equity funds are sitting on a mountain of dry powder – or at least some of them are. The article says that PE & VC funds have added nearly $50 billion to their cash reserves since December 2023.

Private Equity 113

Private Equity Equities Funds Investors 113

JD Supra: Mergers

MAY 22, 2024

On 13 May, a federal district court judge dismissed the Federal Trade Commission’s (FTC) antitrust case against private equity firm Welsh, Carson, Anderson & Stowe and affiliated entities (Welsh Carson). The FTC’s case alleged that Welsh Carson, along with its portfolio company, US Anesthesia Partners, Inc.

Private Equity 161

Private Equity Equities Portfolio Trading 161